HAROLD FRIZZELL: Open Payments
NPI 1578088407 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 41 payments from 10 companies in 2025. Trend: 2023 $1,072 · 2024 $618 · 2025 $909
Food & beverage: $778Education: $130
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $233 |
| Teva Pharmaceuticals USA, Inc. | 12 | $222 |
| Axsome Therapeutics, Inc. | 3 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $82 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| Alkermes, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $42 |
| Corium, LLC | 4 | $32 |
| Braeburn Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: FANAPT, Auvelity, AUSTEDO XR, CAPLYTA, ARISTADA, SPRAVATO, VRAYLAR, Azstarys.
Industry payments across LA — which companies pay providers there.
